shikonin and Pancreatitis

shikonin has been researched along with Pancreatitis* in 1 studies

Other Studies

1 other study(ies) available for shikonin and Pancreatitis

ArticleYear
Shikonin ameliorates cerulein-induced acute pancreatitis in mice.
    Journal of ethnopharmacology, 2013, Jan-30, Volume: 145, Issue:2

    Shikonin, a highly liposoluble naphthoquinone pigment isolated from the traditional medical herbs Lithospermum erythrorhizon (LE), was considered to exhibit an anti-inflammatory property. While the potential of shikonin to ameliorate acute pancreatitis (AP) is unknown. Our aim was to investigate the effects of shikonin in a murine model of cerulein-induced pancreatitis.. AP was induced in mice by six intraperitoneal injection of cerulein (50 μg/kg) at hourly intervals. Vehicle or shikonin (50 mg/kg) was pretreated 2 h before the first cerulein injection. After 6 h, 9 h and 12 h of the first cerulein injection, the severity of acute pancreatitis was assessed by biochemistry, myeloperoxidase activity, histological grading, proinflammatory cytokines levels and nuclear factor kappa B (NF-κB) activity.. Shikonin administration significantly reduced serum amylase and lipase activities, pancreatic histological scores, TNF-α, IL-1β, IL-6 levels, MPO activity and NF-κB activity.. Taken together, these results suggest that shikonin might protect against experimental pancreatitis by reducing release of inflammatory cytokines via inhibition of NF-κB activity. The therapeutic role of shikonin in AP needs further investigation.

    Topics: Animals; Anti-Inflammatory Agents; Ceruletide; Cytokines; Male; Mice; Mice, Inbred BALB C; Naphthoquinones; NF-kappa B; Pancreatitis; Peroxidase; Phytotherapy; RNA, Messenger

2013